Bernhard C Pestalozzi - JoVE Visualize

Showing results (31-40 of 37) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 37 results.

Onkologie|December 18, 2009

Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02)Bernd Klaeser, Egbert Nitzsche, Jan C Schuller, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trialsBernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012

Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)Paulo M Hoff, Andreas Hochhaus, Bernhard C Pestalozzi, et al.

The Lancet. Oncology|February 19, 2013

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)Bernhard C Pestalozzi, Eileen Holmes, Evandro de Azambuja, et al.

BMC Cancer|April 15, 2017

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)Bernhard C Pestalozzi, Christoph Tausch, Konstantin J Dedes, et al.

Clinical Colorectal Cancer|November 13, 2024

Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16Sara Bastian, Markus Joerger, Lisa Holer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008

Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001Jürg Bernhard, Daniel Dietrich, Werner Scheithauer, et al.

Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 37 results.

Onkologie|December 18, 2009

Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02)Bernd Klaeser, Egbert Nitzsche, Jan C Schuller, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trialsBernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012

Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)Paulo M Hoff, Andreas Hochhaus, Bernhard C Pestalozzi, et al.

The Lancet. Oncology|February 19, 2013

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)Bernhard C Pestalozzi, Eileen Holmes, Evandro de Azambuja, et al.

BMC Cancer|April 15, 2017

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)Bernhard C Pestalozzi, Christoph Tausch, Konstantin J Dedes, et al.

Clinical Colorectal Cancer|November 13, 2024

Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16Sara Bastian, Markus Joerger, Lisa Holer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008

Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001Jürg Bernhard, Daniel Dietrich, Werner Scheithauer, et al.

Pageof 4